Osmotic demyelination syndrome with dystonia and parkinsonism responsive to dopaminergic therapy
Objective: To present a case of delayed-onset dystonia and parkinsonism secondary to osmotic demyelination syndrome, with dramatic response to pramipexole 3mg per day. Background: Osmotic…Hydrogen sulfide functions as a neuromodulator to regulate striatal neurotransmission in a mouse model of Parkinson’s disease
Objective: To Evaluate:prepared a MPTP/p induced mouse subacute model of PD, and explore the modulatory effect of H2S on monoamine and amino acid neurotransmitters in…Medicinal cannabis for Parkinson’s disease: A survey of practices, beliefs, and attitudes among providers at NPF centers of excellence
Objective: To gather data on the cannabis-related prescribing practices, and views regarding potential risks and benefits of cannabis, among experts caring for patients with PD.…Pisa syndrome in Parkinson’s disease: A mobile orfixed deformity?
Objective: To study of Pisa syndrome in Parkinson's disease. Background: Although Pisa syndrome and scoliosis are sometimes used interchangeably to describe a laterally flexed postural…Utilization and longitudinal impact of anticholinergic use in Parkinson’s disease. National Parkinson Foundation (NPF) QII registry
Objective: To evaluate baseline predictors and longitudinal impact of anticholinergics use in Parkinson's disease (PD). Background: Anticholinergics have beneficial effect on tremor in PD but…Feasibility, safety and effects of a group intervention based on European physiotherapy guideline for Parkinson´s disease
Objective: To assess the feasibility, safety and effects of an group intervention based on European Physiotherapy Guideline. Background: Studies suggest that exercise may contribute to…Pathological findings from two Parkinson’s disease patients after intraputaminal GDNF infusion
Objective: To describe the postmortem findings from two patients who underwent intraputaminal infusion of glial-derived neurotrophic factor (GDNF). Background: GDNF has been shown to have…Effects of the biodex stability system training on balance, gait and fatigue in Parkinson’s disease
Objective: The purpose of this study was to evaluate the effects of 4 weeks of BSS training on balance, gait and fatigue in PD patients.…A healthy volunteer phase 1 study of RE-024, a potential phosphopantothenate replacement therapy for patients with pantothenate kinase-associated neurodegeneration (PKAN)
Objective: To assess the safety, tolerability, and pharmacokinetics of single oral doses of RE-024 in healthy adult volunteers. Background: PKAN is a rare, autosomal recessive,…Objectivisation of postural disorders in patients with Parkinson’s disease during the screening stage for DBS
Objective: Objectivisation of degree of postural disorders in PD patients during the screening stage for DBS. Background: The neurosurgical treatment of Parkinson's disease (PD) using…
- « Previous Page
- 1
- …
- 331
- 332
- 333
- 334
- 335
- …
- 388
- Next Page »